| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |